STELLA, MARK EDWARD,ENTWISLE, JOHN RICHARD,LUDHER, BALTEJ,CLARK, JONATHAN E.,ANNESS, DAREN,BALAN, GUHAN,CARR, ANDREW NICHOLAS
申请号：
CA3038263
公开号：
CA3038263A1
申请日:
2017.09.25
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
Dosage form has first part and second part. First part can be immediate release section and may include analgestic, can be naproxen or naproxen sodium. Second part can slow-released part and may include pseudoephedrine or its pharmaceutically acceptable salt and/or dextromethorphan or its pharmaceutically acceptable salt. The dosage form optionally includes stabilizer. The dosage form may be adapted to the antalgesic for keeping therapeutically effective amount, pseudoephedrine or its pharmaceutically acceptable salt and/or dextromethorphan or its pharmaceutically acceptable salt, and at least eight hours.
